Psychiatry and Neurology, Neurology · San Antonio, TX
NPI
1396710539
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
255 E Sonterra Blvd, Suite 211
San Antonio, TX, 78258
Phone (210) 656-2333
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
1,532 services
Medicare patients, 2024
770
Average age 75
Drug cost, 2024
$2.7M
4,160 prescriptions
Company payments, 2025
$6,336
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria V Alvarez was code 99214 (office e&m - established), 731 times for 479 patients. In total Maria V Alvarez billed 1,532 services in 26 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 731 | 479 | $80.49 | $59K |
| 99204 Office E&M - New | Office | 192 | 192 | $104.78 | $20K |
| 99213 Office E&M - Established | Office | 179 | 160 | $50.51 | $9,041 |
| 99205 Office E&M - New | Office | 117 | 117 | $139.24 | $16K |
| 99215 Office E&M - Established | Office | 79 | 72 | $116.86 | $9,232 |
| 95983 Electrical Nerve Conductivity | Office | 69 | 37 | $32.04 | $2,211 |
| 95984 Electrical Nerve Conductivity | Office | 53 | 33 | $27.94 | $1,481 |
| 95724 Neurologic | Office | 23 | 23 | $212.40 | $4,885 |
| 95816 Neurologic | Office | 14 | 14 | $38.74 | $542 |
By year: 2022 $145K for 2,892 services; 2023 $123K for 1,386 services; 2024 $128K for 1,532 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria V Alvarez prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,083 prescriptions and refills. In total Maria V Alvarez wrote 4,160 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,083 | 2,808 | 336 | $43K |
| Donepezil Hcl Generic | 296 | 774 | 107 | $3,107 |
| Amantadine Amantadine Hcl | 257 | 586 | 83 | $25K |
| Topiramate Generic | 182 | 460 | 56 | $1,543 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 174 | 434 | 59 | $4,175 |
| Gabapentin Generic | 146 | 306 | 51 | $3,760 |
| Memantine Hcl Generic | 144 | 325 | 43 | $5,628 |
| Primidone Generic | 144 | 336 | 39 | $9,215 |
| Ropinirole Hcl Generic | 122 | 327 | 40 | $4,567 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 114 | 308 | 33 | $14K |
| Rytary Carbidopa/Levodopa | 106 | 184 | 20 | $183K |
| Nuplazid Pimavanserin Tartrate | 88 | 102 | 17 | $516K |
| Ingrezza Valbenazine Tosylate | 79 | 85 | 11 | $781K |
| Austedo Deutetrabenazine | 68 | 68 | Under 11 | $480K |
| Rasagiline Mesylate Generic | 56 | 164 | 18 | $15K |
Brand drugs: 664 claims; generic drugs: 3,496 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria V Alvarez $6,336 ($6,336 in general payments such as food, travel and fees) from 40 companies. The largest payer was UCB, Inc. with $506.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 17 | $506 |
| Neurocrine BioSciences, Inc. NBIX | 22 | $493 |
| Lundbeck LLC | 21 | $470 |
| Pfizer Inc. PFE | 19 | $394 |
| Abbvie Inc. ABBV | 30 | $376 |
| Merz Pharmaceuticals, LLC | 9 | $318 |
| Teva Pharmaceuticals USA, Inc. TEVA | 8 | $295 |
| Medtronic, Inc. MDT | 12 | $280 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $267 |
| ACADIA Pharmaceuticals Inc ACAD | 16 | $238 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.